New York, NY, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Erectile Dysfunction Drugs Market by Drug (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), by Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global erectile dysfunction drugs market was valued at approximately USD 4.82 billion in 2017 and is expected to generate revenue of around USD 7.10 billion by end of 2024, growing at a CAGR of around 5.70% between 2018 and 2024.

The demand for erectile dysfunction drugs is highly growing due to a high incidence rate of chronic diseases including hypertension, neurogenic and psychological disorders, and diabetes. Besides these, rising aged population, alcoholism, sedentary lifestyles, and smoking greatly increases the risk of erectile dysfunction. Growing adoption of these poor lifestyle choices leads to the overall growth of the market for erectile dysfunction drugs. Other factors like patient awareness and education, a growing number of campaigns by government and non-government organizations worldwide to make patients aware of the disease are also other factors responsible for the market growth of erectile dysfunction drugs.

Browse through 54 Tables & 33 Figures spread over 110 Pages and in-depth TOC on “Global Erectile Dysfunction Drugs Market Size & Share 2017 Analysis: By Type, Trends, Growth, Segments and Forecast, 2024”.

Request Free Sample Report of Global Erectile Dysfunction Drugs Market Report @ https://www.zionmarketresearch.com/sample/erectile-dysfunction-drugs-market

The erectile dysfunction drugs market is divided on the basis of drug which is further divided into Sildenafil Citrate (Viagra), Mirodenafil (Mvix), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Stendra/ Spedra (Avanafil), Lodenafil Carbonate (Helleva), and others. Viagra is one of the most widely distributed products worldwide. Viagra dominated the market in terms of revenue and was valued at over USD 2.4 billion in 2014. Though its patent expires by 2019 in the U.S., it is anticipated to account for almost 27% of the market share by the end of 2024 due to its brand loyalty worldwide.

The erectile dysfunction drugs market is categorized on the basis of mode of administration into oral medications, topical medications, injections, and others. The oral medication segment is likely to dominate the market since the first line of treatment or medication for erectile dysfunction comprises of oral medication. Oral phosphodiesterase type 5 inhibitors are commonly used in erectile dysfunction drugs across the globe. Viagra and other PDE 5 inhibitors such as Cialis and Levitra/ Staxyn are extensively consumed for erectile dysfunction treatment thus propelling the market for oral medications.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/erectile-dysfunction-drugs-market

Based on the distribution channel, the market is segmented into online sales, hospital pharmacies, and retail pharmacies. The online sales segment is expected to grow at the highest CAGR over the forecast period. The presence of online sales is a blessing in disguise for several patients who are conscious about visiting a retail pharmacy store to purchase drugs for erectile dysfunction and other sexual wellness products.

North America is expected to be the leading market for erectile dysfunction drugs. The U.S. is the leading pharma market globally and holds almost 92% of the market share in North America. The market for erectile dysfunction drugs in the U.S. is mainly driven by the availability of most recognized brands like Cialis Viagra, and Levitra/Staxyn. However, the looming patent expiration of these branded drugs in the near future is likely to alter the scenario by the end of the forecast period. Besides, major CRO’s have their hubs in this region and due to technological advancement the demand for efficient supplies is increasing in this region which is likely to dominate the market for erectile dysfunction drugs market over the forecast period.

Request the Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/erectile-dysfunction-drugs-market

Europe is the second largest market for erectile dysfunction drugs after North America. The industry participants in Europe considerably spend more on R&D activities and also the region has high healthcare investments and government funding. Development in the emerging areas like orphan drugs and biosimilars is likely to promote the demand for regulatory expertise thereby contributing to the growth of erectile dysfunction drugs market in this region. Besides, sedentary lifestyle, hypertension, stress, anxiety, and chronic diseases are other factors responsible for the growth of the market in Europe.

The Asia Pacific is estimated to showcase high growth potential in the erectile dysfunction drugs market and is also expected to grow at a higher CAGR in comparison to other regions. Countries like China and India are the most attractive markets due to the advantages these countries pose like the availability of government support to develop novel drugs thus attracting more number of manufacturers to invest in this region. Besides this, flourishing generic drugs industry, social stigma, growing base of geriatric population, availability of effective treatment methods, high unmet clinical needs, rising disposable income are also some of the other factors accounting for the fastest growth of this region.

Browse the full "Erectile Dysfunction Drugs Market by Drug (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), by Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/erectile-dysfunction-drugs-market

The Middle East and Africa and Latin America are likely to be the most potential markets owing to the growing access to information, access to new drugs for research and development, and improved patient awareness. Thus, all the aforementioned parameters are expected to propel the erectile dysfunction drugs market globally.

Some of the leading players in erectile dysfunction drugs market include Apricus Biosciences, Bayer AG, Cristália, Eli Lilly and Company, Inc., Pfizer, Inc., Dong-A-Pharmaceutical Co., Ltd., S.K. Chemicals Co., Ltd., Vivus, Inc., Teva Pharmaceutical Industries Ltd., and Meda Pharmaceuticals, Inc. Pfizer, Inc. accounted for almost 40.0% market share in 2012. Yet, the market share of the company is likely to decline due to the patent expiration of Viagra in 2019. However, generics are expected to propel industrial growth. In addition to mergers, acquisitions and collaborations activities, post-patent expiration, and geographic expansion are likely to keep the industry rivalry at higher levels in the forecast period.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/erectile-dysfunction-drugs-market

This report segments the global erectile dysfunction drugs market as follows:

Global Erectile Dysfunction Drugs Market: Drug Segment Analysis

  • Sildenafil Citrate (Viagra)
  • Vardenafil (Levitra/ Staxyn)
  • Tadalafil (Cialis)
  • Udenafil (Zydena)
  • Lodenafil Carbonate (Helleva)
  • Stendra/ Spedra (Avanafil)
  • Mirodenafil (Mvix)
  • Others

Global Erectile Dysfunction Drugs Market: Mode of Administration Segment Analysis

  • Oral Medications
  • Topical Medications
  • Injections
  • Others

Global Erectile Dysfunction Drugs Market: Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Global Erectile Dysfunction Drugs Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com